
Ignite Accelerator


Co-founder
Co-founder James is an accomplished scientist, entrepreneur and investor He has been involved from concept to commercialisation, including CEO, CTO and Board roles, of numerous biotech companies which have resulted in five FDA approved drugs and devices He conceived the technology behind iCeutica Inc (acquired in 2011) and co-discovered the lead therapy for ASX-listed Dimerix Limited (ASX:DXB), currently in Phase 3 trials for Chronic Kidney Disease
James is involved in all phases of investment across the Yuuwa portfolio, and is currently a Director of PolyActiva Pty Ltd and alternate Director of Adalta Limited (ASX:1AD) He remains Chairman of Dimerix and is on the Board of the Perron Institute for Neurological and Translational Science
©2022 by Yuuwa Proudly created with Wix com
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Yuuwa Capital.
Similar listings buyers compare against this one.

Ignite Accelerator

Digital Ventures

AIM Group

SOSV

Sequoia Capital

500 Global
Everything here links back to the same verified catalogue. Pick your next stop.